Introduction
============

Femur neck fracture related to osteoporosis in older patients is steadily increasing. It has become a devastating injury for patients and a substantial burden for the health care system as well.[@b1-cia-13-1639]--[@b3-cia-13-1639] Approximately 250,000 individuals diagnosed with femoral neck fractures need to be treated in the United States, with reported annual costs exceeding \$4.4 billion every year.[@b4-cia-13-1639] Hemiarthroplasty is the most common treatment for displaced femoral neck fractures in older adults, because it can promote early postoperative ambulation, lower reoperation rates, and better functional outcomes in the first year after operation compared with internal fixation.[@b5-cia-13-1639]--[@b7-cia-13-1639] However, hip hemiarthroplasty can still lead to a large amount of blood loss. Actually, the total blood loss (TBL) after surgery for hip fracture is much greater than that observed during the operation.[@b8-cia-13-1639],[@b9-cia-13-1639] After the concept of hidden blood loss (HBL) was put forward in 2000,[@b10-cia-13-1639] more and more studies have provided evidence for HBL in a range of orthopedic surgical procedures, such as hip fracture surgery,[@b8-cia-13-1639],[@b9-cia-13-1639],[@b11-cia-13-1639] total knee[@b10-cia-13-1639],[@b12-cia-13-1639]--[@b14-cia-13-1639] or hip arthroplasty,[@b15-cia-13-1639] and spine surgery.[@b16-cia-13-1639]--[@b20-cia-13-1639] Several authors[@b4-cia-13-1639],[@b21-cia-13-1639]--[@b25-cia-13-1639] have reported the degree of TBL following hemiarthroplasty for femoral neck fracture, but only a few studies[@b8-cia-13-1639] specifically investigated the HBL for hip hemiarthroplasty surgery. Moreover, as far as we know, there is still no published study that has analyzed risk factors for HBL after the hip hemiarthroplasty procedure. The aim of this study was to quantify HBL during hemiarthroplasty surgery in patients with displaced femoral neck fractures and to identify predictors of HBL in these patients.

Patients and methods
====================

Patients
--------

This study was approved by the ethical committee of the Second Affiliated Hospital of Wenzhou Medical University. The need for informed consent from patients was waived by the board, since it was a retrospective cross-sectional study, and all the data were collected and analyzed anonymously without any potential harm to the patients. After that, we performed a retrospective review from our electronic medical record to identify the consecutive patients who underwent hip hemiarthroplasty for displaced femoral neck fractures by the same senior surgeon (more than 15 years of clinical experience in treating femoral neck fractures) between January 2015 and December 2016 at our institution. The inclusion criteria were age \>70 years, unilateral displaced femoral neck fracture, low-energy injury, no previous ipsilateral proximal femoral fracture or surgery, and completed medical data, including blood tests performed preoperatively and on the third day postoperatively. The exclusion criteria were pathological fractures, any other traumatic fracture, neoplastic diseases, and severe hematologic disorders. Finally, a total of 212 patients were included in this study.

Hip hemiarthroplasty procedures
-------------------------------

All hip hemiarthroplasty surgeries were performed through the Moore posterolateral approach in a lateral position with a buttress between two legs. Prophylactic intravenous antibiotics (2 g cefazolin) were administered 30 minutes before the procedures. Uncemented prostheses (LCU, Link, Germany) with bipolar heads were used in all cases. Hemoglobin (Hb) and the hematocrit (Hct) levels were measured in all patients prior to the surgery and on the third postoperative day. Postoperative intravenous cefazolin (2 g, ×3 doses) was administered within the first 24 hours. The drainage tubes were removed 48 hours after the operations. Low-molecular-weight heparin was used from the time the patients were admitted until the operations were done to prevent deep venous thrombosis. All patients received 10 mg of oral rivaroxaban per day postoperatively for at least 1 month.

Transfusion management
----------------------

While transfusion is widely performed when Hb is 80--90 g/L in healthy patients and 100 g/L in patients with severe cardiac disease, due to the institutional policy for restrictive transfusion, transfusions at our institution were performed only when Hb is \<80 or 100 g/L for symptomatic patients (extreme weakness, chest pain, extreme paleness, or major bleeding) with destabilizing vital signs (heart rate, \>100 or systolic blood pressure, \<90 mmHg).

Data collection
---------------

Demographic and medical information were collected for all the patients. Age, gender, height, weight, body mass index (BMI), time to surgery, postoperative length of stay, transfusion volume, comorbidities (including hypertension, diabetes mellitus, cerebrovascular disease, cardiovascular disease, pulmonary disease, renal insufficiency \[creatinine \>200 mmol/L\] and liver disease \[chronic elevation over normal values of SGOT, SGPT, and/or γ-GT because of a known cause such as chronic hepatitis B or C\], preoperative chronic anticoagulation, and perioperative gastrointestinal bleeding/ulcer), and blood tests (including Hb and Hct levels before surgery and on the third postoperative day and preoperative albumin) were recorded by surgeons. Because no patient's BMI was \>30, in our study, we only categorized patients into two groups according to the recommendation of the WHO: underweight group, BMI \<18.5 and normal group, 18.5≤BMI\<30. The patient's American Society of Anesthesiologists (ASA) classification, type of anesthesia, surgical bleeding, and surgical time were assessed and recorded by anesthetists. The intraoperative blood loss was measured as the sum of the blood in suction bottles (after subtracting the lavage fluid used during the surgery) and weighed sponges during the procedure. The volume of the drainage was measured by nurses 48 hours postoperatively.

Calculation of blood loss
-------------------------

The estimated blood volume (EBV) was calculated according to the formula of Nadler et al[@b26-cia-13-1639]: EBV (L)=k1×height (m)[@b3-cia-13-1639]+ k2×weight (kg)+k3 (for male: k1=0.3669, k2=0.03219, and k3=0.6041; for female: k1=0.3561, k2=0.03308, and k3=0.1833).

Total red blood cell volume was calculated by multiplying the EBV by the patient's Hct. Thus, the change in the red blood cell volume can be reflected through the change in Hct. In our study, TBL was calculated according to the Gross's formula[@b27-cia-13-1639]: TBL (L)=EBV (L)×(Hct~pre~-Hct~post~)/Hct~ave~, where Hct~pre~ is the initial preoperative Hct, Hct~post~ is Hct on the third day postoperatively, and Hct~ave~ is the average of Hct~pre~ and Hct~post~. Finally, the HBL was calculated according to the formula of Sehat et al:[@b28-cia-13-1639] HBL=calculated TBL--visible blood loss (intraoperative blood loss+drainage volume). When transfusion was performed during the perioperative period, the formula was calculated as follows: HBL=calculated TBL+blood infusion--visible blood loss.

We assumed that blood volume would be the same on admission as on the third postoperative day, the loss of Hb during the perioperative period was measured as follows: Hb loss (g/L)=Hb~pre~-Hb~post~, where Hb~pre~ is the initial preoperative Hb and Hb~post~ is the Hb on the third day postoperatively.

Statistical analysis
--------------------

Data analysis was performed using SPSS 22.0 for Mac (SPSS Inc., Chicago, IL, USA). Descriptive statistics were shown as mean±SD or number of cases and percentages, where applicable. Student's *t*-test for independent samples was used to test significant differences between males and females. Univariable analysis using Pearson correlation was performed initially to identify variables potentially influencing the HBL. Any variable where the Pearson correlation had a value of *P*\<0.1 was accepted as a candidate for multivariate linear regression analysis to identify the independent risk factors associated with HBL.[@b29-cia-13-1639] A positive coefficient indicates a positive influence on the dependent variable (HBL), whereas a negative coefficient indicates a negative influence. All independent variables were incorporated into the model using the method of "Enter". A value of *P*\<0.05 was considered statistically significant.

Results
=======

We retrospectively reviewed 212 consecutive patients who underwent hip hemiarthroplasty for displaced femoral neck fractures by the same senior surgeon from January 2015 to December 2016, including 57 males and 155 females. The average age was 82.3±5.7 years (range=70--96 years), and the average BMI was 20.6±2.8 (range=14.7--27.7). Demographic data of patients are summarized in [Table 1](#t1-cia-13-1639){ref-type="table"}. No differences were found in age and BMI between males and females (*P*\>0.05). The data for Hct level loss, Hb loss, the number of patients whose Hb\<100 g/L preoperatively and postoperatively, calculated TBL, visible blood loss, HBL, and percentage of HBL are shown in [Table 2](#t2-cia-13-1639){ref-type="table"}. The mean TBL was 859±289 mL, and the mean HBL was 525±217 mL, which accounted for 61.0%±13.6% of TBL. Nineteen (9.0%) patients had an Hb\<100 g/L before surgery, whereas this number increased to 122 (57.5%) postoperatively (*P*\<0.001, chi-squared test).

[Table 3](#t3-cia-13-1639){ref-type="table"} shows the results of univariable analysis between 23 potential risk factors we mentioned earlier and HBL by using Pearson correlation analysis. Finally, six risk factors were involved in multivariate linear regression analysis to examine the association between HBL and these factors. Different levels of HBL between these six risk factors are shown in [Table 4](#t4-cia-13-1639){ref-type="table"}. After multivariate linear regression analysis, as [Table 5](#t5-cia-13-1639){ref-type="table"} shows, higher ASA classification (*P*=0.009), perioperative gastrointestinal bleeding/ulcer (*P*=0.010), and transfusion (*P*\<0.001) were positively correlated with HBL. Compared with women, men had an increased risk of HBL (*P*=0.004), and general anesthesia had an increased risk of HBL compared with spinal anesthesia (*P*=0.018). However, preoperative chronic anticoagulation was not an independent risk factor for HBL. Other factors such as age, BMI category, time to surgery, surgical time, postoperative length of stay, wound drainage, preoperative blood parameters, and comorbidities (except for perioperative gastrointestinal bleeding/ulcer) were not significantly correlated with HBL.

Discussion
==========

Hip hemiarthroplasty may result in less visible blood loss than total hip or knee arthroplasty surgery,[@b30-cia-13-1639] but older patients with displaced femoral neck fractures are physiologically more susceptible to postoperative anemia due to the reasons of older age, higher ASA grade, frailty, and greater concomitant diseases.[@b22-cia-13-1639] Blood loss can result not only from the initial fracture but also from the operation, and it can remain hidden for a period of time even after surgery.[@b31-cia-13-1639] According to previous studies, postoperative anemia after hip fracture surgery is related to an inferior functional recovery and a detrimental effect on mortality.[@b32-cia-13-1639],[@b33-cia-13-1639] In the study by Foss and Kehlet,[@b8-cia-13-1639] the HBL of hip fracture in connection with surgery was an excess of up to six times more than they observed during the operation. Therefore, the HBL of this patient group should not be ignored. Many researchers have referred to the TBL after hemiarthroplasty for femoral neck fractures. Some of them[@b4-cia-13-1639],[@b22-cia-13-1639]--[@b24-cia-13-1639],[@b34-cia-13-1639],[@b35-cia-13-1639] used Hb loss between the preoperative and postoperative periods to evaluate the volume of blood loss. To a certain extent, Hb loss could reflect the perioperative TBL, but this method might not be very accurate; particularly when the transfusion was performed, because the Hb loss would be discounted or lower than it really was. Other authors reported the TBL of hemiarthroplasty for femoral neck fractures ranging from 629 to 737 mL in relatively small population.[@b21-cia-13-1639],[@b25-cia-13-1639] After systematic searches, few researchers are investigating HBL after hip hemiarthroplasty. Foss and Kehlet[@b8-cia-13-1639] found that the HBL after hemiarthroplasty was 987 mL, which accounts for 75% of TBL (1,301 mL), in 167 patients with femoral neck fractures. Although with this relatively large population, their aim was to discover the HBL after different hip fracture surgeries, including screws, hemiarthroplasty, dynamic hip screw and intramedullary nailing, they did not specifically explore the factors that might influence the HBL. According to our understanding, a systematic investigation of HBL after hemiarthroplasty for displaced femoral neck fractures and its risk factors is still lacking.

We performed a detailed investigation on 212 consecutive patients with displaced femoral neck fracture after hip hemiarthroplasty, with relatively complete clinical data, and used a relatively reliable approach for estimating HBL, based on the combination formulas of Nadler et al, Gross, and Sehat, which have been widely used to calculate HBL in orthopedic surgery.[@b12-cia-13-1639],[@b15-cia-13-1639]--[@b19-cia-13-1639] Moreover, some authors[@b15-cia-13-1639],[@b36-cia-13-1639]--[@b38-cia-13-1639] utilized these formulas to calculate the HBL after total hip arthroplasty recently (HBL ranged from 429 to 1,050 mL), which could be considered as one of the reasons for us to use these formulas as well. We found that the HBL after hip hemiarthroplasty was 525±217 mL, accounting for 61.0%±13.6% of TBL (859±289 mL). Our results showed that there was a significant amount of HBL after hip hemiarthroplasty, which should not be ignored for estimating perioperative blood loss, as the number of patients whose Hb\<100 g/L was increased from 9.0% preoperatively to 57.5% postoperatively in our study. Thus, patients must be closely monitored after surgery because of the potential adverse effects of anemia. Similar to previous studies,[@b4-cia-13-1639],[@b22-cia-13-1639]--[@b24-cia-13-1639],[@b34-cia-13-1639],[@b35-cia-13-1639] we found that the perioperative Hb loss was 23.8±7.4 g/L. However, either HBL or TBL in our results was less than that in the research by Foss and Kehlet (HBL=987 mL, TBL=1,301 mL). The reasons might be as follows: The height and weight of our patients were smaller than Westerners, resulting in the calculated TBL based on the patient's height and weight being lower than that in their study consequently.Because of the strict transfusion policy in our hospital (Hb\<80 g/L or 100 g/L for symptomatic patients with destabilizing vital signs), only 29.7% of our patients were transfused.

In the research by Foss and Kehlet, the patients were transfused with blood for a level of Hb\<100 g/L at any point during their admission, and about 50.6% of patients received transfusions after hip fracture surgery. Transfusion has been demonstrated as a risk factor that is associated with increased HBL.[@b15-cia-13-1639] Consistently, after multiple linear regression, we found that blood transfusion was an independent risk factor that can increase the HBL after hip hemiarthroplasty. Pattison et al[@b39-cia-13-1639] speculated that the postoperative blood loss might, at least in part, arise from hemolysis. Moreover, evidence showed that hemolysis would occur after a large number of stored red cells were transfused.[@b40-cia-13-1639],[@b41-cia-13-1639] Thus, we agreed with the view of Miao et al[@b15-cia-13-1639] that patients who received blood transfusion had a higher HBL after hemiarthroplasty, might probably due to hemolysis. In addition, the study suggested that gender, ASA classification, type of anesthesia, and perioperative gastrointestinal bleeding/ulcer were independent risk factors for HBL.

The relationship between gender and HBL is still controversial. Some authors reported that gender was not correlated with HBL,[@b15-cia-13-1639],[@b19-cia-13-1639] and others[@b14-cia-13-1639],[@b16-cia-13-1639] found that gender plays a role in HBL, with a greater contribution in men relative to women. In our series, men had a larger amount of HBL than women. One reasonable explanation might be that men have a greater height and weight than women; consequently, they have a greater calculated blood volume and calculated TBL. The multiple linear analysis also showed that ASA classification was an independent risk factor for HBL. The reason might be that the patient with a higher ASA classification have poor cardiopulmonary compensation, function of coagulation, and level of tolerable anemia than the patient with lower ASA.[@b16-cia-13-1639] Our results showed that the mean HBL of ASA IV was 686±302 mL, which was significantly more than the patients with ASA III (539±212 mL) and ASA II (468±191 mL). In other words, the patients with higher ASA classifications seem to have significant HBL in hip hemiarthroplasty. We found that there was an association between different types of anesthesia and HBL; general anesthesia was associated with higher HBL compared with spinal anesthesia. As general anesthesia causes vasodilation of patients, it not only leads to an increase in intraoperative or postoperative blood loss but also leads to an increase in blood infiltration into the tissue compartments, which causes a higher amount of HBL. An incidence of 6.1% gastrointestinal hemorrhage or ulceration was found in our patients, which has a significantly positive correlation with HBL. It might be easily ignored by surgeons as well.

Our study suffers from several limitations. First, the number of patients included in our cross-sectional study was still relatively small. Thus, our finding should be verified by a large number of patients or multicentre studies in the future. Second, according to the previous research, we used the Hct on the third postoperative day to calculate the TBL, as we assumed that fluid shifts would have been completed in patients at this time. If this is not the case, however, the HBL that was obtained might be falsely low. Finally, we regularly used rivaroxaban to prevent venous thromboembolism postoperatively; however, evidence[@b41-cia-13-1639]--[@b43-cia-13-1639] has shown that rivaroxaban for thromboprophylaxis after hip arthroplasty will increase major bleeding or clinically relevant bleeding postoperatively, which might then affect the volume of HBL.

Conclusion
==========

The current study indicates that HBL is a significant portion of TBL in patients after hip hemiarthroplasty for displaced femoral neck fractures. Female patients, patients with higher ASA classification and perioperative gastrointestinal bleeding/ulcer, patients who were administered general anesthesia, or patients who underwent transfusion had a greater amount of HBL after hip hemiarthroplasty was performed. HBL and its risk factors should also be taken into account when considering the perioperative strategies of fluid infusion and blood transfusion. The more effectively HBL is controlled, the better the rehabilitation of patients.
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###### 

Characteristics of the patients

  Parameters                                                Men        Women      Total
  --------------------------------------------------------- ---------- ---------- ----------
  Number of patients                                        57         155        212
  Age (years)                                               82.2±6.0   82.3±5.6   82.3±5.7
  Height (m)[\*](#tfn2-cia-13-1639){ref-type="table-fn"}    1.7±0.3    1.6±0.5    1.6±0.1
  Weight (kg)[\*](#tfn2-cia-13-1639){ref-type="table-fn"}   59.8±8.5   51.7±9.5   53.9±9.9
  BMI (kg/m^2^)                                             20.4±3.0   21.0±2.5   20.6±2.8

**Notes:** Data are represented as mean±SD.

*P*\<0.001.

**Abbreviation:** BMI, body mass index.

###### 

Perioperative parameters of the patients

  Parameters                                 Mean±SD or n (%)
  ------------------------------------------ ------------------
  Hematocrit level loss (%)                  20.0±5.1
  Hemoglobin loss (g/L)                      23.8±7.4
  Hemoglobin \<100 g/L preoperatively (n)    19 (9.0%)
  Hemoglobin \<100 g/L postoperatively (n)   122 (57.5%)
  Calculated total blood loss (mL)           859±289
  Visible blood loss (mL)                    334±169
  Hidden blood loss (mL)                     525±217
  Percentage of hidden loss in total (%)     61.0±13.6

###### 

Perioperative parameters of the patients and results of Pearson correlation analysis for hidden blood loss

  Parameters                                       n (%) or mean±SD    Pearson's *r*   *P*-value
  ------------------------------------------------ ------------------- --------------- -----------
  Age (years), mean (range)                        82.3±5.7 (70--96)   0.086           0.213
  Gender (men/women)                               155/57              0.165           0.016
  BMI category (kg/m^2^)                                               0.079           0.253
   BMI\<18.5                                       54 (25.5)                           
   18.5≤BMI\<30                                    130 (61.3)                          
  ASA classification                                                   0.232           0.001
   II                                              70 (33.0)                           
   III                                             129 (60.9)                          
   IV                                              13 (6.1)                            
  Type of anesthesia                                                   0.176           0.010
   General                                         36 (17.0)                           
   Spinal                                          176 (83.0)                          
  Comorbid conditions                                                                  
   Hypertension                                    175 (82.6)          0.093           0.178
   Diabetes mellitus                               55 (25.9)           0.100           0.148
   Cerebrovascular disease                         39 (18.4)           0.064           0.355
   Cardiovascular disease                          35 (16.5)           0.079           0.254
   Pulmonary disease                               36 (17.0)           0.088           0.204
   Renal insufficiency                             7 (3.3)             0.053           0.446
   Liver disease                                   10 (4.7)            0.093           0.175
   Chronic anticoagulation preoperatively          59 (27.8)           0.153           0.026
   Perioperative gastrointestinal bleeding/ulcer   13 (6.1)            0.179           0.009
  Blood parameters                                                                     
   Preoperative hematocrit                         0.36±0.04           0.010           0.884
   Preoperative hemoglobin (g/L)                   118.8±15.1          −0.040          0.563
   Preoperative albumin (g/L)                      37.1±11.3           −0.018          0.797
   Time to surgery (days)                          3.0±2.0             0.057           0.409
   Surgical time (minutes)                         71.6±17.8           0.089           0.196
   Intraoperative blood loss (mL)                  182±96              −0.046          0.506
   Wound drainage (mL)                             162±112             0.048           0.486
   Transfusion                                     63 (29.7)           0.393           0.000
   Postoperative length of stay (days)             9.0±3.6             0.085           0.216

**Abbreviations:** ASA, American Society of Anesthesiologists; BMI, body mass index.

###### 

Hidden blood loss among different clinical factors

  Clinical factors                                Mean hidden blood loss (mL)
  ----------------------------------------------- -----------------------------
  Gender                                          
   Men                                            584±213
   Women                                          503±216
  ASA classification                              
   II                                             468±191
   III                                            539±212
   IV                                             686±302
  Type of anesthesia                              
   General                                        583±221
   Spinal                                         500±212
  Chronic anticoagulation preoperatively          
   Yes                                            578±225
   No                                             504±212
  Perioperative gastrointestinal bleeding/ulcer   
   Yes                                            676±185
   No                                             515±216
  Transfusion                                     
   Yes                                            656±208
   No                                             469±197

**Abbreviation:** ASA, American Society of Anesthesiologists.

###### 

Multiple linear regression analysis on risk factors of HBL after hemiarthroplasty

                                                  Coefficient B   SE       95% CI for B         *P*-value
  ----------------------------------------------- --------------- -------- -------------------- ---------------------------------------------------
  Constant                                        298.989         43.432   213.358 to 384.618   0.000[\*](#tfn6-cia-13-1639){ref-type="table-fn"}
  Gender (men/women)                              87.414          29.857   28.547 to 146.280    0.004[\*](#tfn6-cia-13-1639){ref-type="table-fn"}
  ASA classification                              62.169          23.612   15.616 to 108.722    0.009[\*](#tfn6-cia-13-1639){ref-type="table-fn"}
  Type of anesthesia (general/spinal)             68.920          29.019   11.707 to 126.134    0.018[\*](#tfn6-cia-13-1639){ref-type="table-fn"}
  Chronic anticoagulation preoperatively          30.678          29.360   −27.208 to 88.563    0.297
  Perioperative gastrointestinal bleeding/ulcer   155.589         59.593   38.095 to 273.083    0.010[\*](#tfn6-cia-13-1639){ref-type="table-fn"}
  Transfusion                                     192.118         28.677   135.578 to 248.659   0.000[\*](#tfn6-cia-13-1639){ref-type="table-fn"}

**Notes:**

*P*\<0.05. Multiple linear regression analysis adjusted for all variables in the table. The adjusted *R*^2^=0.52.

**Abbreviations:** ASA, American Society of Anesthesiologists; HBL, hidden blood loss; SE, standard error.
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